4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001470831-25-000409
Chief Financial Officer gave up 155 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Sullivan Christopher Ryan · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-10 | Shares withheld for taxes : show line 1 in the form | −155 | $4.10 | $636 | 17,338 | D |
Loading xslF345X05/form4.xml…